Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup...
The European Commission (EC) has agreed to amend the conditions of use for novel vitamin B3 ingredient nicotinamide riboside chloride (NR) in foods for special medical purposes and total diet replacement for weight control.
America’s nicotinamide riboside (NR) maker Chromadex is eyeing omnichannel retail in China and is confident of achieving the ‘blue-hat’ health foods registration status – required for normal trade of health foods in China – in the next 24 months or less....
Branded ingredient supplier ChromaDex announced an 18% sales gain in a recent earrings report. A continued push to increase the science behind its TruNiagen brand is part of the reason, the company’s co-founder said.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
Yasmeen Nkrumah-Elie, PhD, oversees external Research, managing a portfolio of over 200 studies, as well as supporting marketing, regulatory, and scientific affairs projects. The Global Director of External Research for ChromaDex has over 13 years of...
Personalised nutrition and other specific therapeutic functions with a focus on changing the concept of ageing are the way forward for ChromaDex’s flagship nicotinamide riboside (NR) supplement, said the firm.
Canadian supplement company NeutriSci has now dropped all sales of ChromaDex’s pTeroPure ingredient in favor of an energy product line based upon its PurEnergy ingredient, which is a pTeroPure/caffeine co crystal.
Branded dietary ingredient supplier ChromaDex reported record revenue in its second quarter 2015 earnings statement. It was the fifth consecutive quarter in which the company reached a new earnings plateau.
A single dose of nicotinamide riboside (NR) may significantly increases levels of NAD+, which is key to cellular energy metabolism and mitochondrial function, says a new study with healthy human volunteers using ChromaDex’s Niagen NR.
ChromaDex has bolstered the IP protection around pTeroPure, one of its branded ingredients, with the announcement of two patents relating to pterostilbene, which are the second and third patents granted to the company on the ingredient.
Chromadex has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, a move that will allow the Californian company to explore new topics and to accelerate its existing pipeline.
ChromaDex Corp. today announced the introduction of a new ingredient, called PURENERGY, which is a patented co-crystal ingredient comprised of caffeine and the company’s synthetic pterostilbene ingredient pTeroPure. The announcement comes on the heels...
Alabama-based biotechnology firm DiscoveryBioMed (DBM) has partnered with Californian botanical specialist ChromaDex to tap into the group’s phytochemical expertise as it steps up work on the development of anti-inflammatory drugs.
ChromaDex is launching an ingredient with similar properties to resveratrol having obtained commercial rights to the biological compound from the University of Mississippi and the Agriculture Research Service (ARS).